Overview
Zinc thymulin, also known as FTS-Zn (Facteur Thymique Sérique-Zinc), is the biologically active form of thymulin, a nonapeptide hormone (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) secreted by thymic epithelial cells. Thymulin is unique among thymic hormones in that it requires zinc binding for biological activity—the apo-form (zinc-free thymulin) is immunologically inert. This zinc dependency makes thymulin a molecular link between zinc nutrition, thymic function, and immune competence.
Discovered in the 1970s by Jean-François Bach and colleagues at Hôpital Necker in Paris, thymulin was initially identified as a serum factor that could restore T-cell function in thymectomized mice. Subsequent work revealed that thymulin circulates as a zinc-metallopeptide complex, and that zinc deficiency—a common nutritional deficit affecting over 2 billion people worldwide—directly impairs thymulin activity and T-cell immunity.
Thymulin production peaks during puberty and declines progressively with age, paralleling thymic involution. By age 60, circulating active thymulin is nearly undetectable. This age-related decline correlates with immunosenescence—the deterioration of immune function that increases susceptibility to infections, cancer, and autoimmune disease in the elderly. Zinc thymulin supplementation has been explored as a strategy to reverse aspects of immunosenescence.
More recently, zinc thymulin has gained attention for hair growth applications, as thymulin receptors are expressed on hair follicle cells and zinc is essential for keratinocyte proliferation. Topical and injectable zinc thymulin preparations are being studied for androgenetic alopecia.
Quick facts
- Mechanism
- Zinc-dependent thymic peptide regulating T-cell maturation and immune balance
- Primary use
- Immune Modulation & Hair Growth
- Evidence
- moderate
- FDA
- Not approved
- Route
- Subcutaneous injection or topical (for hair)
- Typical results
- Immune modulation effects observed within 2–4 weeks; hair growth studies show improved density over 3–6 months
Chemical information
Zinc Thymulin (C₃₃H₅₄N₁₂O₁₅ + Zn) is a immune modulation compound with a molecular weight of 858.86 g/mol. Its structural characteristics underpin its biological activity in immune system modulation.
How Zinc Thymulin works
Zinc thymulin binds to specific receptors on T-cell precursors (thymocytes) and peripheral T-cells, promoting their differentiation, maturation, and functional activation. The zinc ion is coordinated by the peptide's Asn residue and adjacent backbone atoms, creating the biologically active conformation that enables receptor recognition. Without zinc, thymulin adopts an inactive conformation incapable of receptor binding.
In the thymus, zinc thymulin acts at multiple stages of T-cell development. It promotes the differentiation of CD4⁻CD8⁻ double-negative thymocytes into CD4⁺CD8⁺ double-positive cells, then guides positive and negative selection that shapes the T-cell repertoire. In the periphery, thymulin modulates T-cell cytokine production, promoting IL-2 and IFN-γ (Th1 responses) while suppressing excessive IL-4 and IL-13 (Th2 responses), contributing to immune balance.
Zinc thymulin also enhances natural killer (NK) cell cytotoxicity and macrophage phagocytic activity, suggesting broad innate immune modulation beyond its T-cell-specific effects. In aged animals, zinc thymulin administration has been shown to partially restore thymic architecture, increase thymic cellularity, and improve T-cell-dependent antibody responses to vaccination.
For hair growth, zinc thymulin appears to act through multiple mechanisms: direct stimulation of hair follicle stem cells in the bulge region, modulation of local inflammatory microenvironment (reducing follicular miniaturization in androgenetic alopecia), and enhancement of zinc-dependent enzymes essential for keratin synthesis and hair shaft formation. The peptide may also counteract the inhibitory effects of DHT on hair follicle dermal papilla cells.
- T-cell maturation: Promotes thymocyte differentiation from DN to DP stage and guides selection
- Zinc-dependent activation: Zn²⁺ coordination creates the biologically active receptor-binding conformation
- Cytokine modulation: Balances Th1/Th2 responses for appropriate immune regulation
- NK cell enhancement: Increases natural killer cell cytotoxicity against infected and malignant cells
- Hair follicle stimulation: Activates follicular stem cells and supports zinc-dependent keratin synthesis
Pharmacokinetics
| Parameter | Value | Significance |
|---|---|---|
| Molecular Weight | 858.86 g/mol (peptide) + 65.38 g/mol (Zn) | Small peptide-metal complex amenable to multiple administration routes |
| Half-life | ~15–30 minutes (circulating) | Rapid clearance; effects mediated through sustained receptor signaling |
| Zinc Requirement | Equimolar Zn²⁺ essential | Biological activity is completely zinc-dependent |
| Circulating Levels | Decline from puberty to near-zero by age 60 | Age-related decline correlates with immunosenescence |
Dosing & administration
Zinc Thymulin dosing varies by indication and individual factors. No FDA-approved dosing exists for this compound; protocols in the literature derive from limited clinical or preclinical data and practitioner experience.
Any use should be conducted under qualified medical supervision with appropriate monitoring of safety markers.
Important: These dosing ranges are not FDA-approved. Any use should be under qualified medical supervision.
Side effects & safety
Safety data for Zinc Thymulin is primarily derived from preclinical studies and limited human data. Long-term effects in humans remain incompletely characterized.
Common
- • Restores T-cell function in zinc-deficient and aged individuals
- • Enhances immune response to vaccination in elderly populations
- • Modulates inflammatory balance reducing autoimmune tendencies
- • Potential hair regrowth effects through follicle stem cell activation
- • Addresses the molecular link between zinc deficiency and immune dysfunction
- • May partially reverse age-related thymic involution
Serious / potential risks
- • Generally well-tolerated at therapeutic doses
- • Injection site reactions (mild, transient)
- • Theoretical risk of immune overstimulation in autoimmune conditions
- • Zinc accumulation concerns with chronic high-dose use
- • Limited clinical trial data for most indications
- • May exacerbate certain autoimmune conditions by enhancing T-cell activity
Drug interactions
| Medication | Interaction | Recommendation |
|---|---|---|
| Zinc supplements | Essential cofactor | Ensure adequate zinc status; zinc deficiency renders thymulin inactive |
| Immunosuppressants (Cyclosporine) | Opposing effects | Zinc thymulin enhances immune function; may partially counteract immunosuppression |
| Thymosin Alpha-1 | Complementary immune modulation | Different mechanisms; combination may provide broader immune support |
| Copper supplements (high dose) | Competitive zinc absorption | High copper can reduce zinc bioavailability; maintain appropriate Zn:Cu ratio |
Storage & handling
Lyophilized (powder)
- • Store at -20°C to 4°C (freezer or refrigerator)
- • Protect from light and moisture
- • Stable for 12–24 months when stored properly
- • Keep in original sealed container until reconstitution
Reconstituted solution
- • Refrigerate at 2–8°C after reconstitution
- • Use bacteriostatic water for multi-dose reconstitution
- • Typical stability: 14–28 days refrigerated
- • Do not freeze reconstituted solution
Cost & availability
| Source | Cost | Notes |
|---|---|---|
| Research suppliers | Varies widely | Quality and purity vary significantly between sources |
| Compounding pharmacies | Prescription required | Higher quality assurance and purity testing |
The bottom line
Zinc Thymulin is a immune modulation compound with research interest in immune modulation, t-cell maturation, thymus, hair growth. While preclinical evidence is encouraging, it remains investigational and is not FDA-approved. Any use should be under qualified medical supervision.
Best for
- • Researchers studying immune system modulation
- • Individuals interested in immune modulation under medical guidance
Not for
- • Self-administration without medical supervision
- • Pregnant or breastfeeding individuals
- • Individuals with contraindicated conditions
Related compounds
Frequently asked questions
References
- [1] Bach JF, Dardenne M.. Thymulin, a zinc-dependent hormone. Med Oncol Tumor Pharmacother (1989). doi: 10.1007/BF02934395 PMID: 2657521
- [2] Mocchegiani E, Muzzioli M, Giacconi R.. Zinc and immunoresistance to infection in aging: new biological tools. Trends Pharmacol Sci (2000). doi: 10.1016/S0165-6147(00)01535-4 PMID: 10884550
- [3] Dardenne M, Savino W, Borrih S, Bach JF.. A zinc-dependent epitope on the molecule of thymulin, a thymic hormone. Proc Natl Acad Sci USA (1985). doi: 10.1073/pnas.82.20.7049 PMID: 3863140
- [4] Prasad AS.. Zinc in human health: effect of zinc on immune cells. Mol Med (2008). doi: 10.2119/2008-00033.Prasad PMID: 18587227